Microglia toxicity in preterm brain injury

Reproductive Toxicology

Volumn 48, Issue , 2014, Pages 106-112

  Baburamani, Ana A ^a   Supramaniam, Veena G ^a,b   Hagberg, Henrik ^a,b   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Neuroinflammation; Perinatal brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPA RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 2; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN INJURY; CELL ACTIVATION; CELL FUNCTION; CYTOTOXICITY; DISEASE ASSOCIATION; ENCEPHALOMALACIA; EXCITOTOXICITY; GRAY MATTER; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PREMATURITY; WHITE MATTER INJURY; ANIMAL; BRAIN DISEASE; METABOLISM; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL INJURY;

ANIMALIA;

ANIMALS; BRAIN DISEASES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MICROGLIA; PRENATAL INJURIES;

EID: 84906790490     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.04.002     Document Type: Article

References (126)

1. Wake H., Moorhouse A.J., Nabekura J. Functions of microglia in the central nervous system - beyond the immune response. Neuron Glia Biol 2011, 7:47-53.
2. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
3. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
4. Ginhoux F., Lim S., Hoeffel G., Low D., Huber T. Origin and differentiation of microglia. Front Cell Neurosci 2013, 7:45.
5. Smith P.L., Hagberg H., Naylor A.S., Mallard C. Neonatal peripheral immune challenge activates microglia and inhibits neurogenesis in the developing murine hippocampus. Dev Neurosci. 2014, [Epub ahead of print PMID:24642725].
6. Tremblay M.E., Stevens B., Sierra A., Wake H., Bessis A., Nimmerjahn A. The role of microglia in the healthy brain. J Neurosci 2011, 31:16064-16069.
7. Cunningham C.L., Martinez-Cerdeno V., Noctor S.C. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 2013, 33:4216-4233.
8. Hagberg H. Glycine and modulation of the NMDA receptor after severe asphyxia. Acta Paediatr 1999, 88:1049-1050.
9. McRae A., Gilland E., Bona E., Hagberg H. Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res 1995, 84:245-252.
10. Szaflarski J., Ivacko J., Liu X.H., Warren J.S., Silverstein F.S. Excitotoxic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. Brain Res Dev Brain Res 1998, 55:306-314.
11. Tahraoui S.L., Marret S., Bodenant C., Leroux P., Dommergues M.A., Evrard P., et al. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001, 11:56-71.
12. Moore T., Hennessy E.M., Myles J., Johnson S.J., Draper E.S., Costeloe K.L., et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. Br Med J 2012, 345:e7961.
13. Wood N.S., Marlow N., Costeloe K., Chir B., Gibson A.T., Wilkinson A.R. Neurologic and developmental disability after extremely preterm birth. N Engl J Med 2000, 343:378-384.
14. Marlow N., Wolke D., Bracewell M.A., Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005, 352:9-19. EPICure Study Group.
15. Counsell S.J., Rutherford M.A., Cowan F.M., Edwards A.D. Magnetic resonance imaging of preterm brain injury. Arch Dis Child Fetal Neonatal Ed 2003, 88:F269-F274.
16. Inder T.E., Huppi P.S., Warfield S., Kikinis R., Zientara G.P., Barnes P.D., et al. Periventricular white matter injury in the premature infants is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 1999, 46:755-760.
17. Ajayi-Obe M., Saeed N., Cowan F.M., Rutherford M.A., Edwards A.D. Reduced development of cerebral cortex in extremely preterm infants. Lancet 2000, 356:1162-1163.
18. Ricci D., Anker S., Cowan F., Pane M., Gallini F., Luciano R., et al. Thalamic atrophy in infants with PVL and cerebral visual impairment. Early Hum Dev 2006, 82:591-595.
19. Ball G., Srinivasan L., Aljabar P., Counsell S.J., Durighel G., Hajnal J.V., et al. Development of cortical microstructure in the preterm human brain. Proc Natl Acad Sci U S A 2013, 110:9541-9546.
20. Rutherford M.A., Supramaniam V., Ederies A., Chew A., Bassi L., Groppo M., et al. Magnetic resonance imaging of white matter diseases of prematurity. Neuroradiology 2010, 52:505-521.
21. Volpe J.J. The encephalopathy of prematurity-brain injury and impaired brain development inextricably intertwined. Pediatr Neurol 2009, 16:167-178.
22. Haynes R.L., Borenstein N.S., DeSilva T.M., Folkerth R.D., Liu L.G., Volpe J.J., et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 2005, 484:156-167.
23. Supramaniam V., Vontell R., Srinivasan L., Wyatt-Ashmead J., Hagberg H., Rutherford M. Microglia activation in the extremely preterm human brain. Pediatr Res 2013, 73:301-309.
24. Verney C., Podledic I., Biran V., Adle-Biassette H., Fallet-Bianco C., Gressens P. Microglial reaction in axonal crossroads is a hallmark of noncystic periventricular white matter injury in very preterm infants. J Neuropathol Exp Neurol 2012, 71:251-264.
25. Monier A., Adle-Biassette H., Delezoide A.L., Evrard P., Gressens P., Verney C. Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex. J Neuropathol Exp Neurol 2007, 66:372-382.
26. Verney C., Monier A., Fallet-Bianco Gressens P. Early microglial colonization of the human forebrain and possible involvement in periventricular white matter injury of preterm infants. J Anat 2010, 217:436-448.
27. Rezaie P. Microglia in the human nervous system during development. Neuroembryology 2003, 2:18-31.
28. Rezaie P., Male D. Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech 1999, 45:359-382.
29. Judas M., Rados M., Jovanov-Milosevic N., Hrabac P., Stern-Padovan R., Kostovic I. Structural, immunocytochemical, and MR imaging properties of periventricular crossroads of growing cortical pathways in preterm infants. Am J Neuroradiol 2005, 26:2671-2784.
30. Innocenti G.M., Clarke S., Koppel H. Transitory macrophages in the white matter of the developing visual cortex. II. Development and relations with axonal pathways. Brain Res 1983, 313:55-66.
31. Billiards S.S., Haynes R.L., Folkerth R.D., Trachtenberg F.L., Liu L.G., Volpe J.J., et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 2006, 497:199-208.
32. Haynes R.L., Folkerth R.D., Keefe R.J., Sung I., Swzeda L.I., Rosenberg P.A., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003, 62:441-450.
33. Kadhim H., Tabarki G., De Perez C., Rona A.M., Sebire G. Interleukin-2 in the pathogenesis of perinatal white matter damage. Neurol India 2002, 58:1125-1128.
34. Kadhim H., Tabarki G., Verellen G., De Perex C., Rona A.M., Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278-1284.
35. Haynes R.L., Folkerth R.D., Trachtenberg F.L., Volpe J.J., Kinney H.C. Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalacia. Acta Neuropathology 2009, 118:391-399.
36. Billiards S.S., Haynes R.L., Folkerth R.D., Borenstein N.S., Trachtenberg F.L., Rowitch D.H., et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008, 18:153-163.
37. Ligam P., Haynes R.L., Folkerth R.D., Yang M.Y., Volpe J.J., Kinney H.C. Thalamic damage in periventricular leukomalacia: novel pathologic observations relevant to cognitive deficits in survivors of prematurity. Pediatr Res 2009, 65:524-529.
38. Vontell R., Supramaniam V., Thornton C., Wyatt-Ashmead J., Mallard C., Gressens P., et al. Toll-like receptor 3 expression in glia and neurons alters in response to white matter injury in preterm infants. Dev Neurosci 2013, 35:130-139.
39. Kinney H.C., Haynes R.L., Xu G., Andiman S.E., Folkerth R.D., Sleeper L.A., et al. Neuron deficit in the white matter and subplate in periventricular leukomalacia. Ann Neurol 2012, 71:397-406.
40. Morgan J.T., Chana G., Abramson I., Semendeferi K., Courchesne E., Everall I.P. Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 2012, 1456:72-81.
41. Anderson P., Doyle L.W. Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990. J Am Med Assoc 2003, 289:3264-3272. Victorian Infant Collaborative Study G.
42. Johnson S., Hollis C., Kochhar P., Hennessy E., Wolke D., Marlow N. Psychiatric disorders in extremely preterm children: longitudinal finding at age 11 years in the EPICure study. J Am Acad Child Adolesc Psychiatry 2010, 49:453-463. e1.
43. Ment L.R., Hirtz D., Huppi P.S. Imaging biomarkers of outcome in the developing preterm brain. Lancet Neurol 2009, 8:1042-1055.
44. Buser J.R., Maire J., Riddle A., Gong X., Nguyen T., Nelson K., et al. Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 2012, 71:93-109.
45. Dyet L.E., Kennea N., Counsell S.J., Maalouf E.F., Ajayi-Obe M., Duggan P.J., et al. Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment. Pediatrics 2006, 118:536-548.
46. Georgiadis P., Xu H., Chua C., Hu F., Collins L., Huynh C., et al. Characterization of acute brain injuries and neurobehavioral profiles in a rabbit model of germinal matrix hemorrhage. Stroke 2008, 39:3378-3388.
47. Kannan S., Saadani-Makki F., Balakrishnan B., Chakraborty P., Janisse J., Lu X., et al. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure. Dev Neurosci 2011, 33:231-240.
48. Mallard C., Welin A.K., Peebles D., Hagberg H., Kjellmer I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 2003, 28:215-223.
49. Dean J.M., Farrag D., Zahkouk S.A., El Zawahry E.Y., Hagberg H., Kjellmer I., et al. Cerebellar white matter injury following systemic endotoxemia in preterm fetal sheep. Neuroscience 2009, 160:606-615.
50. Dean J.M., van de Looij Y., Sizonenko S.V., Lodygensky G.A., Lazeyras F., Bolouri H., et al. Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann Neurol 2011, 70:846-856.
51. Keller M., Enot D.P., Hodson M.P., Igwe E.I., Deigner H.P., Dean J., et al. Inflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injury. PLoS ONE 2011, 6:e29503.
52. Duncan J.R., Cock M.L., Scheerlinck J.P., Westcott K.T., McLean C., Harding R., et al. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res 2002, 52:941-949.
53. Keogh M.J., Bennet L., Drury P.P., Booth L.C., Mathai S., Naylor A.S., et al. Subclinical exposure to low-dose endotoxin impairs EEG maturation in preterm fetal sheep. Am J Physiol Regul Integr Comp Physiol 2012, 303:R270-R278.
54. Nitsos I., Rees S.M., Duncan J., Kramer B.W., Harding R., Newnham J.P., et al. Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. J Soc Gynecol Investig 2006, 13:239-247.
55. Hutton L.C., Castillo-Melendez M., Smythe G.A., Walker D.W. Microglial activation, macrophage infiltration, and evidence of cell death in the fetal brain after uteroplacental administration of lipopolysaccharide in sheep in late gestation. Am J Obstet Gynecol 2008, 198:117 e1-e1211.
56. Du X., Fleiss B., Li H., D'Angelo B., Sun Y., Zhu C., et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS ONE 2011, 6:e19583.
57. Favrais G., van de Looij Y., Fleiss B., Ramanantsoa N., Bonnin P., Stoltenburg-Didinger G., et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 2011, 70:550-565.
58. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000, 108(Suppl. 3):511-533.
59. Watson R.E., Desesso J.M., Hurtt M.E., Cappon G.D. Postnatal growth and morphological development of the brain: a species comparison. Birth Defects Res B Dev Reprod Toxicol 2006, 77:471-484.
60. Semple B.D., Blomgren K., Gimlin K., Ferriero D.M., Noble-Haeusslein L.J. Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 2013, 10:6-107. 1-16.
61. Reddy K., Mallard C., Guan J., Marks K., Bennet L., Gunning M., et al. Maturational change in the cortical response to hypoperfusion injury in the fetal sheep. Pediatr Res 1998, 43:674-682.
62. Hedtjarn M., Leverin A.L., Eriksson K., Blomgren K., Mallard C., Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002, 22:5910-5919.
63. Liu X.H., Kwon D., Schielke G.P., Yang G.Y., Silverstein F.S., Barks J.D. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 1999, 19:1099-1108.
64. Eklind S., Mallard C., Leverin A.L., Gilland E., Blomgren K., Mattsby-Baltzer I., et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001, 13:1101-1106.
65. Rousset C.I., Kassem J., Olivier P., Chalon S., Gressens P., Saliba E. Antenatal bacterial endotoxin sensitizes the immature rat brain to postnatal excitotoxic injury. J Neuropathol Exp Neurol 2008, 67:994-1000.
66. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003, 100:8514-8519.
67. Wang X., Stridh L., Li W., Dean J., Elmgren A., Gan L., et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009, 183:7471-7477.
68. Stridh L., Mottahedin A., Johansson M.E., Valdez R.C., Northington F., Wang X., et al. Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia. J Neurosci 2013, 33:12041-12051.
69. Kendall G.S., Hristova M., Horn S., Dafou D., Acosta-Saltos A., Almolda B., et al. TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult. Lab Invest 2011, 91:328-341.
70. Girard S., Sebire H., Brochu M.E., Briota S., Sarret P., Sebire G. Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav Immun 2012, 26:1331-1339.
71. Yang D., Sun Y.Y., Lin X., Baumann J.M., Dunn R.S., Lindquist D.M., et al. Intranasal delivery of cell-penetrating anti-NF-kappaB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury. Exp Neurol 2013, 247:447-455.
72. Bolouri H., Savman K., Wang W., Thomas A., Maurer N., Dullaghan E., et al. Innate defense regulator peptide 1018 protects against perinatal brain injury. Ann Neurol. 2014, 75(3):395-410.
73. Biber K., Owens T., Boddeke E. What is microglia neurotoxicity (Not)?. Glia 2014, 62(6):841-854.
74. Hellwig S., Heinrich A., Biber K. The brain's best friend: microglial neurotoxicity revisited. Front Cell Neurosci 2013, 7:71.
75. Coltman B.W., Ide C.F. Temporal characterization of microglia, IL-1 beta-like immunoreactivity and astrocytes in the dentate gyrus of hippocampal organotypic slice cultures. Int J Dev Neurosci 1996, 14:707-719.
76. Czapiga M., Colton C.A. Function of microglia in organotypic slice cultures. J Neurosci Res 1999, 56:644-651.
77. Hailer N.P., Jarhult J.D., Nitsch R. Resting microglial cells in vitro: analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures. Glia 1996, 18:319-331.
78. Henn A., Lund S., Hedtjarn M., Schrattenholz A., Porzgen P., Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex 2009, 26:83-94.
79. Stansley B., Post J., Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease. J Neuroinflammation 2012, 9:115.
80. Butovsky O., Jedrychowski M.P., Moore C.S., Cialic R., Lanser A.J., Gabriely G., et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 2014, 17:131-143.
81. Lai A.Y., Dibal C.D., Armitage G.A., Winship I.R., Todd K.G. Distinct activation profiles in microglia of different ages: a systematic study in isolated embryonic to aged microglial cultures. Neuroscience 2013, 254:185-195.
82. Kim S.J., Li J. Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia. Cell Death Dis 2013, 4:e716.
83. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009, 27:119-145.
84. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418.
85. Luo X.G., Chen S.D. The changing phenotype of microglia from homeostasis to disease. Transl Neurodegener 2012, 1:9.
86. Liu B., Wang K., Gao H.M., Mandavilli B., Wang J.Y., Hong J.S. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem 2001, 77:182-189.
87. Chhor V., Le Charpentier T., Lebon S., Ore M.V., Celador I.L., Josserand J., et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun 2013, 32:70-85.
88. Possel H., Noack H., Keilhoff G., Wolf G. Life imaging of peroxynitrite in rat microglial and astroglial cells: role of superoxide and antioxidants. Glia 2002, 38:339-350.
89. Pathipati P., Muller S., Jiang X., Ferriero D. Phenotype and secretory responses to oxidative stress in microglia. Dev Neurosci 2013, 35:241-254.
90. Doverhag C., Keller M., Karlsson A., Hedtjarn M., Nilsson U., Kapeller E., et al. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol Dis 2008, 31:133-144.
91. Sankarapandi S., Zweier J.L., Mukherjee G., Quinn M.T., Huso D.L. Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch Biochem Biophys 1998, 353:312-321.
92. Wang T., Qin L., Liu B., Liu Y., Wilson B., Eling T.E., et al. Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J Neurochem 2004, 88:939-947.
93. Rojo A.I., McBean G., Cindric M., Egea J., Lopez M.G., Rada P., et al. Redox control of microglial function: molecular mechanisms and functional significance. Antioxid Redox Signal 2014.
94. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69.
95. Cheret C., Gervais A., Lelli A., Colin C., Amar L., Ravassard P., et al. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J Neurosci 2008, 28:12039-12051.
96. Mead E.L., Mosley A., Eaton S., Dobson L., Heales S.J., Pocock J.M. Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions. J Neurochem 2012, 121:287-301.
97. Visentin S., Renzi M., Frank C., Greco A., Levi G. Two different ionotropic receptors are activated by ATP in rat microglia. J Physiol 1999, 519(Pt 3):723-736.
98. Walz W., Ilschner S., Ohlemeyer C., Banati R., Kettenmann H. Extracellular ATP activates a cation conductance and a K+ conductance in cultured microglial cells from mouse brain. J Neurosci 1993, 13:4403-4411.
99. Mingam R., De Smedt V., Amedee T., Bluthe R.M., Kelley K.W., Dantzer R., et al. In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain. Brain Behav Immun 2008, 22:234-244.
100. Haynes S.E., Hollopeter G., Yang G., Kurpius D., Dailey M.E., Gan W.B., et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 2006, 9:1512-1519.
101. Honda S., Sasaki Y., Ohsawa K., Imai Y., Nakamura Y., Inoue K., et al. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 2001, 21:1975-1982.
102. Dou Y., Wu H.J., Li H.Q., Qin S., Wang Y.E., Li J., et al. Microglial migration mediated by ATP-induced ATP release from lysosomes. Cell Res 2012, 22:1022-1033.
103. Kaindl A.M., Degos V., Peineau S., Gouadon E., Chhor V., Loron G., et al. Activation of microglial N-methyl-d-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 2012, 72:536-549.
104. Taylor D.L., Jones F., Kubota E.S., Pocock J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 2005, 25:2952-2964.
105. Byrnes K.R., Stoica B., Loane D.J., Riccio A., Davis M.I., Faden A.I. Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 2009, 57:550-560.
106. Taylor D.L., Diemel L.T., Pocock J.M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J Neurosci 2003, 23:2150-2160.
107. Noda M., Nakanishi H., Nabekura J., Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 2000, 20:251-258.
108. Domercq M., Vazquez-Villoldo N., Matute C. Neurotransmitter signaling in the pathophysiology of microglia. Front Cell Neurosci 2013, 7:49.
109. Eun S.Y., Hong Y.H., Kim E.H., Jeon H., Suh Y.H., Lee J.E., et al. Glutamate receptor-mediated regulation of c-fos expression in cultured microglia. Biochem Biophys Res Commun 2004, 325:320-327.
110. Barger S.W., Goodwin M.E., Porter M.M., Beggs M.L. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem 2007, 101:1205-1213.
111. Takaki J., Fujimori K., Miura M., Suzuki T., Sekino Y., Sato K. l-Glutamate released from activated microglia downregulates astrocytic l-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular l-glutamate concentration in neuroinflammation. J Neuroinflammation 2012, 9:275.
112. Zajicek J.P., Wing M., Scolding N.J., Compston D.A. Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 1992, 115(Pt 6):1611-1631.
113. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993, 151:2132-2141.
114. Miller B.A., Crum J.M., Tovar C.A., Ferguson A.R., Bresnahan J.C., Beattie M.S. Developmental stage of oligodendrocytes determines their response to activated microglia in vitro. J Neuroinflammation 2007, 4:28.
115. Domercq M., Sanchez-Gomez M.V., Sherwin C., Etxebarria E., Fern R., Matute C. System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 2007, 178:6549-6556.
116. He L.F., Chen H.J., Qian L.H., Chen G.Y., Buzby J.S. Curcumin protects pre-oligodendrocytes from activated microglia in vitro and in vivo. Brain Res 2010, 1339:60-69.
117. Li J., Baud O., Vartanian T., Volpe J.J., Rosenberg P.A. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A 2005, 102:9936-9941.
118. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci 2008, 28:5321-5330.
119. Sudo S., Tanaka J., Toku K., Desaki J., Matsuda S., Arai T., et al. Neurons induce the activation of microglial cells in vitro. Exp Neurol 1998, 154:499-510.
120. Kaushal V., Schlichter L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci 2008, 28:2221-2230.
121. Lai A.Y., Todd K.G. Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 2008, 56:259-270.
122. Azevedo E.P., Ledo J.H., Barbosa G., Sobrinho M., Diniz L., Fonseca A.C., et al. Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis. Cell Death Dis 2013, 4:e789.
123. Dean J.M., Wang X., Kaindl A.M., Gressens P., Fleiss B., Hagberg H., et al. Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain Behav Immun 2010, 24:776-783.
124. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992, 149:2736-2741.
125. Sumi N., Nishioku T., Takata F., Matsumoto J., Watanabe T., Shuto H., et al. Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cell Mol Neurobiol 2010, 30:247-253.
126. Yenari M.A., Xu L., Tang X.N., Qiao Y., Giffard R.G. Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 2006, 37:1087-1093.